Bioniche Life Sciences Inc. (TSX/ASX: BNC) has completed its previously announced US $20 million term loan financing from Capital Royalty L.P. managed funds, Capital Royalty Partners II L.P., Capital Royalty Partners II...
To Read This Article, Please Login or Subscribe
For $5 plus HST a month (recurring), you will have access to all our premium contents (database access is not included). For database subscription, please click here.
